Vitality: Promoting Cognitive Function in Older Adults With Chronic Stroke
NCT01916486, Not applicable, Completed, University of British Columbia
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Vitality: Promoting Cognitive Function in Older Adults With Chronic Stroke | ClinicalTrials.gov |
| NCT number | NCT01916486 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 120 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University of British Columbia | ClinicalTrials.gov |
| Conditions | Stroke, Chronic Stroke | ClinicalTrials.gov |
| Interventions | Exercise training, Complex mental and social activities, Control: stretching and relaxation program | ClinicalTrials.gov |
| First posted | 2013-08-05 | ClinicalTrials.gov |
| Last updated | 2020-08-28 | ClinicalTrials.gov |
Registered outcomes 25
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change from baseline in cognitive function as measured by the Alzheimer's Disease Assessment Scale Cognitive Subscale Plus (ADAS-Plus) at 6 months | Baseline and 6 months | ADAS-Cog 13 + additional measures of executive functions. For ADAS-Cog 13, higher scores indicate greater impairment. | ClinicalTrials.gov |
| Secondary | Change from baseline in executive functions as measured by the Stroop Test. | Baseline, 3 months (for subset of cognitive outcomes), 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in executive functions as measured by the Tower of London Test. | Baseline, 3 months (for subset of cognitive outcomes), 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in processing speed and executive functions as measured by the Trail Making Tests (Parts A & B). | Baseline, 3 months (for subset of cognitive outcomes), 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in category fluency. | Baseline, 3 months (for subset of cognitive outcomes), 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in memory and executive functions as measured by the verbal digits forward and backward tests. | Baseline, 3 months (for subset of cognitive outcomes), 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in instrumental activities of daily living as measured by the Instrumental Activities of Daily Living Scale. | Baseline, 3 months, 6 months, and 12 months | Higher scores indicate better performance. | ClinicalTrials.gov |
| Secondary | Change from baseline in fatigue as measured by the Fatigue Severity Scale. | Baseline, 3 months, 6 months, and 12 months | Higher scores indicate greater fatigue. | ClinicalTrials.gov |
| Secondary | Change from baseline in physical activity level as measured by the Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS). | Baseline, 3 months, 6 months, and 12 months | Acquired on a monthly basis. Higher scores indicate greater activity. | ClinicalTrials.gov |
| Secondary | Change from baseline in community mobility as measured by the Life-space Assessment (LSA). | Baseline, 3 months, 6 months, and 12 months | Higher scores indicate greater community mobility. | ClinicalTrials.gov |
| Secondary | Change from baseline in leisure activity as measured by the Shortened Nottingham Leisure Scale. | Baseline, 3 months, 6 months, and 12 months | Acquired on a monthly basis. Higher scores indicate greater leisure activity. | ClinicalTrials.gov |
| Secondary | Change from baseline in general balance and mobility as measured by the Short Physical Performance Battery. | Baseline, 3 months, 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in functional capacity as measured by the 6 Minute Walk Test. | Baseline, 3 months, 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in general balance and mobility as measured the Timed Up-and-Go Test. | Baseline, 3 months, 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in quadriceps strength. | Baseline, 3 months, 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in grip strength. | Baseline, 3 months, 6 months, and 12 months | ClinicalTrials.gov | |
| Secondary | Change from baseline in mood as measured by the Center for Epidemiologic Studies Depression Scale. | Baseline, 3 months, 6 months, and 12 months | Higher scores indicate greater impairment in mood. | ClinicalTrials.gov |
| Secondary | Change from baseline in quality of life as measured by the European Quality of Life-5 Dimensions (EQ-5D). | Baseline, 3 months, 6 months, and 12 months | Acquired on a monthly basis. | ClinicalTrials.gov |
| Secondary | Change from baseline in quality of life as measured by European Quality of Life-5 Dimensions Visual Analog Scale (EQ-5D VAS). | Baseline, 3 months, 6 months, and 12 months | Acquired on a monthly basis. | ClinicalTrials.gov |
| Secondary | Change from Baseline in Cognitive Function as Measured by the Alzheimer's Disease Assessment Scale Cognitive Subscale Plus (ADAS-Cog Plus) at 12 months | Baseline, 3 months, 6 months, and 12 months | ADAS-Cog 13 + additional measures of executive functions. For ADAS-Cog Plus, higher scores indicate greater impairment. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 3
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Category Fluency | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Tower Planning | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)